BioCentury
ARTICLE | Company News

Breakthrough designation for Pfizer's meningococcal B vaccine

March 20, 2014 11:58 PM UTC

Pfizer Inc. (NYSE:PFE) said FDA granted breakthrough therapy designation for bivalent rLP2086 to prevent meningococcal B disease. The designation was based in part on data from two Phase II trials in ...